Until · 3 weeks ago
Research Associate, Molecular Development
Until is a moonshot company focused on developing reversible cryopreservation technologies for organ preservation. As a Research Associate, you will execute and analyze high-throughput molecular discovery experiments, collaborating with interdisciplinary teams to advance innovative solutions.
BiotechnologyLife Science
Responsibilities
Execute high-throughput screening (HTS) assays to support a molecular discovery pipeline, utilizing automated liquid handlers
Perform microplate-based assays (fluorescence, luminescence, absorbance), microscopy, and genomics (qPCR, RNA-seq) experiments to support the molecular discovery pipeline
Maintain and experiment with various mammalian cell-based in vitro models (immortalized, primary and stem cells)
Collaborate closely with cross-functional teams to translate experimental findings into practical solutions
Ensure meticulous, accurate, and timely experimental collection, data analysis, and data reporting/presentation
Qualification
Required
You have an undergraduate and/or master's degree in Bioengineering, Molecular Biology, Biochemistry, Neuroscience, Immunology, or a related field
2+ years of experience in a similar role and a record of success performing complex laboratory procedures. Prior industry experience is preferred
You have a good understanding of cryopreservation (vitrification, cryoprotectants, ice nucleation/growth)
You demonstrate an ability to work in a multidisciplinary lab environment and rapidly learn new skills in other fields. Prior exposure to interdisciplinary projects bridging biology and engineering is strongly preferred
You have experience independently maintaining and working with mammalian cell lines. Prior experience with 3D in vitro models is strongly preferred
You demonstrate agency, problem solving, passion for discovery, and a drive to push the boundaries of science through meaningful involvement in an ambitious project
Preferred
Prior industry experience is preferred
Prior exposure to interdisciplinary projects bridging biology and engineering is strongly preferred
Prior experience with 3D in vitro models is strongly preferred
Company
Until
We are building reversible cryopreservation technology to solve the organ procurement and matching problem.
Funding
Current Stage
Early StageTotal Funding
$106MKey Investors
Founders Fund
2025-09-22Series A· $58M
2024-06-06Series A· $48M
Recent News
2025-11-28
Company data provided by crunchbase